Cynthia Firnhaber is an Infectious Disease physician affiliated with University of Colorado Anschutz. OpenAlex indexes 115 publications with 2,193 citations (h-index 26); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Registry record last updated 27 Oct 2016.
Clinical trials
- Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
Sponsor: University of Witwatersrand, South Africa
- Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202515 payments$10,376openpaymentsdata.cms.gov ↗
- ViiV Healthcare CompanyProgram year20254 payments
- Gilead Sciences, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug–Drug Interactions With Antiretroviral and Antituberculosis Treatment
Clinical Pharmacology & Therapeutics
2021 - Delay to diagnosis and breast cancer stage in an urban South African breast clinic
South African Medical Journal
2019 - Discordant rifampicin susceptibility results are associated with Xpert<sup>®</sup> MTB/RIF probe B and probe binding delay
The International Journal of Tuberculosis and Lung Disease
2019
Similar KOLs
Other experts from the same institution or the same specialty.
David Badesch, MD
University of Colorado Anschutz
Sarit Polsky, MD, MPH
University of Colorado Anschutz
Maria Nagel, MD
University of Colorado Anschutz
Tyler Buckner, MD
University of Colorado Anschutz
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”